Gregory P. Hanson
2015 - MabVax Therapeutics Holdings
In 2015, Gregory P. Hanson earned a total compensation of $2.2M as Chief Financial Officer at MabVax Therapeutics Holdings, a 790% increase compared to previous year.
Compensation breakdown
| Bonus | $77,175 |
|---|---|
| Option Awards | $773,006 |
| Salary | $271,819 |
| Stock Awards | $1,075,480 |
| Other | $19,742 |
| Total | $2,217,222 |
Hanson received $1.1M in stock awards, accounting for 49% of the total pay in 2015.
Hanson also received $77.2K in bonus, $773K in option awards, $271.8K in salary and $19.7K in other compensation.
Rankings
In 2015, Gregory P. Hanson's compensation ranked 4,325th out of 13,638 executives tracked by ExecPay. In other words, Hanson earned more than 68.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,325 out of 13,638 | 68th |
Division Manufacturing | 1,581 out of 5,190 | 70th |
Major group Chemicals And Allied Products | 572 out of 1,854 | 69th |
Industry group Drugs | 453 out of 1,528 | 70th |
Industry Pharmaceutical Preparations | 357 out of 1,182 | 70th |
Source: SEC filing on May 2, 2017.
Hanson's colleagues
We found three more compensation records of executives who worked with Gregory P. Hanson at MabVax Therapeutics Holdings in 2015.